Dr. Charles A Thornton MD
Neurologist | Vascular Neurology
601 Elmwood Ave Box 278984 Rochester NY, 14642About
Dr. Charles Thornton is a distinguished Neurologist in Rochester, NY. Dr. Thornton specializes in diagnosing, treating, and managing disorders of the brain and nervous system. With expertise in handling complex conditions like epilepsy, multiple sclerosis, and migraines, Dr. Thornton employs advanced techniques and personalized treatment plans to improve patient outcomes. As a neurologist, Dr. Thornton is committed to staying abreast of the latest developments in neurological research and therapies.
Education and Training
Univ Of Ia Coll Of Med- Iowa City Ia 1981
University of Ia Roy J & L Carver Com 1981
Baylor College of Medicine, Houston, Texas 1981
Board Certification
Psychiatry and NeurologyAmerican Board of Psychiatry and NeurologyABPN
Provider Details
Expert Publications
Data provided by the National Library of Medicine- Expanded CUG repeats trigger aberrant splicing of ClC-1 chloride channel pre-mRNA and hyperexcitability of skeletal muscle in myotonic dystrophy.
- Computational method for reducing variance with Affymetrix microarrays.
- Myotonic syndromes.
- Molecular fingerprints of inflammatory myopathies.
- Reduced amount of mitochondrial DNA in aged human muscle.
- Gene expression profile of aging in human muscle.
- A muscleblind knockout model for myotonic dystrophy.
- Ribonuclear inclusions in skeletal muscle in myotonic dystrophy types 1 and 2.
- Skeletal muscle gene expression profiles in 20-29 year old and 65-71 year old women.
- Myotonic dystrophy type 1 is associated with nuclear foci of mutant RNA, sequestration of muscleblind proteins and deregulated alternative splicing in neurons.
- Truncated ClC-1 mRNA in myotonic dystrophy exerts a dominant-negative effect on the Cl current.
- Nuclear RNA foci in the heart in myotonic dystrophy.
- Failure of MBNL1-dependent post-natal splicing transitions in myotonic dystrophy.
- Reversal of RNA missplicing and myotonia after muscleblind overexpression in a mouse poly(CUG) model for myotonic dystrophy.
- RNA-dominant diseases.
Treatments
- Muscular Dystrophy
- Amyotrophic Lateral Sclerosis (als)
Professional Memberships
- Fellow 2005- American Academy of Neurology
- Member Scientific Advisory Board, Senator Paul D Wellstone Muscular Dystrophy Cooperative Research Center 2006
- Member American Society of Gene Therapy 2008
Dr. Charles A Thornton MD's Practice location
Rochester, NY 14642Get Direction
Dr. Charles A Thornton MD's reviews
Write ReviewPatient Experience with Dr. Thornton
Recommended Articles
- What Are the Signs and Symptoms of Multiple Sclerosis?
Multiple sclerosis is an autoimmune disease in which the protective myelin sheath of the nerves is damaged, affecting the transmission of messages to and from the brain and spinal cord. This is a progressive, debilitating disease that results in nerve deterioration which is, unfortunately, an...
- Multiple Sclerosis: Coping with Grief
Just hearing the word grief can evoke feelings of sadness, but is grief just “being sad”? Or is it something more complex? The word itself seems to have a stronger meaning than “sad.”According to the Mayo Clinic, for many people, including those diagnosed with a chronic illness, grief is a...
- Tips On Living With Epilepsy
Get to Know Your EpilepsyEpilepsy can affect people at any point in their life. There’s no specific race or gender that have a higher incidence rate of epilepsy. Until now, there was no single cause of epilepsy. The causes of epilepsy range from head injuries to birth defects to tumors and...
- What is the Difference Between Dementia and Alzheimer’s Disease?
Most people think that Alzheimer’s disease and dementia are the same thing and use the names interchangeably. However, it is important that you know that they both are not the same. Even though the risk of dementia and Alzheimer’s disease increases with aging, it is not a normal part of...
- Is Multiple Sclerosis Hereditary?
Research organizations were able to identify and pinpoint two genes that affect the development of multiple sclerosis. Seven genome screens of MS in November 2010 revealed that other complex genetic factors have associations with MS. For this reason, more research is called for to reveal the...
- New Multiple Sclerosis Treatment, Ocrevus, Slows Down Disease Progression
In 2017, the United States Food and Drug Administration (USFDA) approved the drug – Ocrevus (ocrelizumab) – as a treatment for both relapsing and progressive forms of multiple sclerosis. ...
Nearby Providers
- Dr. James Azurin MD MS2101 Lac Deville Boulevard Rochester NY 14618
- Dr. I-hweii Amy Chen MD1425 Portland Ave Rochester NY 14621
- Dr. Emma Ciafaloni MD601 Elmwood Ave Rochester NY 14642
- Dr. Adilia M Hormigo MD, PHD601 Elmwood Ave Rochester NY 14642
- Dr. Michel J Berg MD601 Elmwood Ave Rochester NY 14642
- Dr. Michael W Chilungu MD1425 PORTLAND AVE ROCHESTER NY 14621